Good news from Pfizer Bionic … on vaccine and storage temperature

Good news regarding its vaccine, the American company Pfizer and the German company Biontech announced on Friday that they had submitted new data to the American Food and Drug Administration (FDA) indicating the stability of the Covid-19 vaccine when stored between 25 degrees. below zero and 15 degrees below zero degrees, and they said the data may allow storage at normal temperatures in drugstore refrigerators and freezers.

In the event that the new data is approved, the easing of the requirements will significantly reduce transport and storage costs, as the vaccine currently needs to be stored at minus 70 degrees Celsius, which is especially difficult in low-income countries that do not have the infrastructure to store in Super cold temperatures.

The data was provided to the United States Food and Drug Administration to support a proposal to change emergency clearance recommendations, allowing vaccine vials to be stored at these temperatures for up to two weeks in total instead. storage in refrigerators at very low temperatures. .

من جهته, قال الرئيس التنفيذي والشريك المؤسس لشركة بيونتيك أوجور شاهين “كانت أولويتنا القصوى تطوير لقاح آمن وفعال بسرعة وإتاحته للأشخاص الأكثر ضعفا في العالم من أجل إنقاذ الأرواح في الوقت نفسه, قمنا باستمرار بجمع البيانات التي يمكن أن تتيح التخزين عند حوالي -20. ° C “.

From Brazil on February 8, 2021

Pharmacies and vaccination centers

He also added that “the data provided may facilitate the circulation of our vaccine in pharmacies and allow vaccination centers more flexibility. We will continue to benefit from our experience to develop potential new formulations which could make our vaccine easier to use. transport and use “.

Both companies have confirmed that the new data will also be submitted to global regulators in a matter of weeks.

It should be noted that the Pfizer and Biontech vaccine, as well as the Moderna vaccine, have obtained emergency use authorization in the United States and are widely distributed as part of the comprehensive immunization efforts in the country.